Sensitive and rapid quantification of C-reactive protein using quantum dot-labeled microplate immunoassay

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Luo, Yang ^a   Zhang, Bo ^a   Chen, Ming ^b   Jiang, Tianlun ^a   Zhou, Daiyang ^a   Huang, Junfu ^a   Fu, Weiling ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

C reactive protein; Cardiovascular disease; Fluoroimmunoassay; Quantification; Quantum dots

Indexed keywords

ANTIGEN; C REACTIVE PROTEIN; EPITOPE; MONOCLONAL ANTIBODY; QUANTUM DOT; IMMOBILIZED PROTEIN;

ACCURACY; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LIMIT OF DETECTION; NEPHELOMETRY; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; CALIBRATION; CROSS REACTION; FLUORESCENCE; INSTRUMENTATION; METABOLISM; METHODOLOGY; PHOTOMETRY; SENSITIVITY AND SPECIFICITY; STAINING; TIME;

C-REACTIVE PROTEIN; CALIBRATION; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HUMANS; IMMOBILIZED PROTEINS; IMMUNOASSAY; LIMIT OF DETECTION; NEPHELOMETRY AND TURBIDIMETRY; QUANTUM DOTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; TIME FACTORS;

EID: 84856578407     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-24     Document Type: Article

References (33)

1. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002, 105:1760-1763.
2. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
3. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
4. Kim SH, Reaven G, Lindley S. Relationship between insulin resistance and C-reactive protein in a patient population treated with second generation antipsychotic medications. Int Clin Psychopharmacol 2011, 26:43-47.
5. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
6. Wu TL, Tsai IC, Chang PY, Tsao KC, Sun CF, Wu LL, Wu JT. Establishment of an in-house ELISA and the reference range for serum amyloid A (SAA): complementarity between SAA and C-reactive protein as markers of inflammation. Clin Chim Acta 2007, 376:72-76.
7. Kjelgaard-Hansen M, Kristensen AT, Jensen AL. Evaluation of a commercially available enzyme-linked immunosorbent assay (ELISA) for the determination of C-reactive protein in canine serum. J Vet Med A, Physiol, Pathol, Clin Med 2003, 50:164-168.
8. Sisman AR, Kume T, Tas G, Akan P, Tuncel P. Comparison and evaluation of two C-reactive protein assays based on particle-enhanced immunoturbidimetry. J Clin Lab Anal 2007, 21:71-76.
9. Ceron JJ, Martinez-Subiela S, Caldin M, Parra MD, Ottolini N, Bertolini G, Bernal LJ, Garcia-Martinez JD. Canine C-reactive protein measurements in cerebrospinal fluid by a time-resolved immunofluorimetric assay. J Vet Diagn Invest 2011, 23:63-67.
10. Kilpatrick EL, Liao W, Turko IV, Camara JE, Dodder NG, Bunk DM. Quantification of C-reactive protein in human serum with affinity purification and isotope-dilution tandem mass spectrometry. Clin Chem 2009, 55:A205-A206.
11. Muddiman DC, Williams DK. Absolute quantification of c-reactive protein in human plasma derived from patients with epithelial ovarian cancer utilizing protein cleavage isotope dilution mass spectrometry. J Proteome Res 2009, 8:1085-1090.
12. Dixit CK, Vashist SK, MacCraith BD, O'Kennedy R. Multisubstrate-compatible ELISA procedures for rapid and high-sensitivity immunoassays. Nat Protoc 2011, 6:439-445.
13. Dixit CK, Vashist SK, O'Neill FT, O''Reilly B, MacCraith BD, O'Kennedy R. Development of a high sensitivity rapid sandwich ELISA procedure and its comparison with the conventional approach. Anal Chem 2010, 82:7049-7052.
14. Yamamori H, Khatoon S, Grundke-Iqbal I, Blennow K, Ewers M, Hampel H, Iqbal K. Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification. Neurosci Lett 2007, 418:186-189.
15. Danese A, Ouellet-Morin I, Williams B, Arseneault L. Validation of a high-sensitivity assay for C-reactive protein in human saliva. Brain Behav Immun 2011, 25:640-646.
16. Sok D, Clarizia LJ, Farris LR, McDonald MJ. Novel fluoroimmunoassay for ovarian cancer biomarker CA-125. Anal Bioanal Chem 2009, 393:1521-1523.
17. Lu H, Schops O, Woggon U, Niemeyer CM. Self-assembled donor comprising quantum dots and fluorescent proteins for long-range fluorescence resonance energy transfer. J Am Chem Soc 2008, 130:4815-4827.
18. Chen L, Algar WR, Tavares AJ, Krull UJ. Toward a solid-phase nucleic acid hybridization assay within microfluidic channels using immobilized quantum dots as donors in fluorescence resonance energy transfer. Anal Bioanal Chem 2011, 399:133-141.
19. Shaheen SM, Akita H, Yamashita A, Katoono R, Yui N, Biju V, Ishikawa M, Harashima H. Quantitative analysis of condensation/decondensation status of pDNA in the nuclear sub-domains by QD-FRET. Nucleic Acids Res 2011, 39:e48.
20. Niu S, Li Q, Qu L, Wang W. Nicking endonuclease and target recycles signal amplification assisted quantum dots for fluorescence detection of DNA. Anal Chim Acta 2010, 680:54-58.
21. Qian J, Dai H, Pan X, Liu S. Simultaneous detection of dual proteins using quantum dots coated silica nanoparticles as labels. Biosens Bioelectron 2011, 28:314-319.
22. Di Corato R, Bigall NC, Ragusa A, Dorfs D, Genovese A, Marotta R, Manna L, Pellegrino T. Multifunctional nanobeads based on quantum dots and magnetic nanoparticles: synthesis and cancer cell targeting and sorting. ACS Nano 2011, 5:1109-1121.
23. Roederer M, Chattopadhyay PK, Price DA, Harper TF, Betts MR, Yu J, Gostick E, Perfetto SP, Goepfert P, Koup RA, et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat Med 2006, 12:972-977.
24. Nie SM, Liu JA, Lau SK, Varma VA, Kairdolf BA. Multiplexed Detection and Characterization of Rare Tumor Cells in Hodgkin's Lymphoma with Multicolor Quantum Dots. Anal Chem 2010, 82:6237-6243.
25. Willner I, Freeman R, Finder T, Gill R. Probing Protein Kinase (CK2) and Alkaline Phosphatase with CdSe/ZnS Quantum Dots. Nano Lett 2010, 10:2192-2196.
26. Zhu X, Duan D, Publicover NG. Magnetic bead based assay for C-reactive protein using quantum-dot fluorescence labeling and immunoaffinity separation. Analyst 2010, 135:381-389.
27. Kerman K, Endo T, Tsukamoto M, Chikae M, Takamura Y, Tamiya E. Quantum dot-based immunosensor for the detection of prostate-specific antigen using fluorescence microscopy. Talanta 2007, 71:1494-1499.
28. Miao WJ, Wang SJ, Harris E, Shi JA, Chen A, Parajuli S, Jing XH. Electrogenerated chemiluminescence determination of C-reactive protein with carboxyl CdSe/ZnS core/shell quantum dots. Phys Chem Chem Phys 2010, 12:10073-10080.
29. McBride JD, Cooper MA. A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing. J Nanobiotechnol 2008, 6:5.
30. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evaluation of nine automated high-sensitivity c-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001, 47:418-425.
31. Lolekha PH, Chittamma A, Roberts WL, Sritara P, Cheepudomwit S, Suriyawongpaisal P. Comparative study of two automated high-sensitivity C-reactive protein methods in a large population. Clin Biochem 2005, 38:31-35.
32. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 2000, 46:461-468.
33. Price CP, Trull AK, Berry D, Gorman EG. Development and Validation of a Particle-Enhanced Turbidimetric Immunoassay for C-Reactive Protein. J Immunol Methods 1987, 99:205-211.